HHS Extends Broad Immunity for Liability Arising From COVID-19 Countermeasures



DOCUMENTS
  • Notice


WASHINGTON, D.C. — The United States Department of Health has conferred broad-based tort immunity for drug and medical device makers and others engaging in “activities related to medical countermeasures against COVID-19.”

According to a March 17 notice of declaration published in the Federal Register, the immunity extends to “any claim of loss caused by, arising out of, relating to, or resulting from the manufacture, distribution, administration, or use of medical countermeasures.”

The immunity extends to “any claim of loss caused by, arising out of, relating to, or resulting from the manufacture, distribution, administration, or use of medical countermeasures,” and …






UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: Acetaminophen ASD/ADHD Product Liability Litigation

October 21, 2022

MORE DETAILS



HarrisMartin's Webinar Series: The Hottest Upcoming Device Projects - Strattice Hernia Mesh & Exactech Hip Implants

November 09, 2022

MORE DETAILS